HYDRAGEL LIPOPROTEIN (E) - COFEPRIS Registration 1364R2020 SSA
Access comprehensive regulatory information for HYDRAGEL LIPOPROTEIN (E) (HYDRAGEL LIPOPROTEIN (E)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1364R2020 SSA and manufactured by LABORATORIOS LICON, S.A.. The device was registered on October 08, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LOSKITSHYDRAGEL7,15Y30LIPOPROTEIN(E)ESTÁN DISEÑADOS PARA LA DETERMINACIÓNDELOSPERFILESLIPOPROTÉICOS.ELANÁLISISSELLEVAACABOMEDIANTEELECTROFORESISENGELESDEAGAROSATAMPONADOS(PH8.6)EN EL INSTRUMENTO SEMIAUTOMÁTICOHYDRASYS.LASLIPOPROTEÍNASSEPARADASSETIÑENCONUNASOLUCIÓNDENEGROSUDÁN.EL EXCESO DE COLORANTE SE ELIMINA CONUNA SOLUCIÓN DE ALCOHOL. LOSELECTROFORETOGRAMAS RESULTANTESPUEDENSEREVALUADOSVISUALMENTEPARAUNA VALORACIÓN CUALITATIVA, O MEDIANTEDENSI
THE HYDRAGEL7,15Y30LIPOPROTEIN(E) KITS ARE DESIGNED FOR THE DETERMINATION OF LIPOPROTEIN PROFILES. ANALYSIS IS carried out by electrophoresisengelesdeagarosabufferados (PH8.6) IN THE SEMI-AUTOMATIC INSTRUMENT HYDRASYS. SEPARATE LIPOPROTEINS ARE MADE WITH A SOLUTION OF BLACKSUDAN.THE EXCESS DYE IS REMOVED WITH AN ALCOHOL SOLUTION. THE RESULTING ELECTROPHORETOGRAMS CAN BE EVALUATED VISUALLY FOR QUALITATIVE ASSESSMENT, OR BY